Join us at the 5th Annual COMPANION DIAGNOSTICS FORUM.   Companion Diagnostics can provide information that is essential for the safe and effective use of a corresponding therapeutic product, sometimes for specific patient populations. Companion Diagnostics can identify patients who are most likely to benefit from that product, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.

CALL FOR ABSTRACTS 2020:

Each year welcomes increasing numbers of drugs and biologics supported by assays designed to indicate the safety and/or efficacy for specified populations.  While this is a positive sign for precision diagnostics and therapeutics in general, several issues have arisen in the course of testing drugs and assays, e.g., finding more precise biomarkers, developing drugs for unmet needs.  Solutions are being discovered, but the “elephant in the room” continues to be why only a percent of any population responds to any given therapy. And, what can be done for those patients with unmet needs? So lots left to do! Moving to the next level will take advocating for an organization-wide, systemic adoption of precision medicine to realize the full potential of this paradigm. Subsequent success requires building broad alliances in this space and making the case for market-driven uptake. For this year’s Forum, we are calling for abstracts that consider scientific, technical, and organizational solutions to issues relating to the uptake and use of precision medicine.  Come join us! 

We look forward to your abstracts and participation. Event topics this year include:

• Biomarkers – Discovery and Clinical Development
• Technology/Frameworks
• Precision Medicine
• Business Models and Partnerships
• Regulatory Issues
• Reimbursement
• Standardization
• Drug and Diagnostics Pricing Transparency

2019 Keynote Speakers

Jeff Evelhoch

Vice President, Head of Translational Biomarkers
Merck & Co.

Steve Anderson

Senior Vice President
LabCorp

Some of the Organizations who have Participated

Call For Abstracts

Developing and Launching Precision Diagnostics and Therapeutics